Depomed Rejected Horizon Pharma's Takeout Bid, But Still Trades As If M&A Is Happening

By: via Benzinga
In a report published Thursday, RBC Capital analyst Randall Stanicky downgraded the rating on Depomed Inc(NASDAQ: DEPO) from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.